Thus, it is possible that in patients with T2D incretin hormones are able to produce the expected increase in calcium and to stimulate exocytosis, but the effects on secretion are transient because of lack of adequate granule supply (or de novo insulin biosynthesis). The gene discussed is GCG; the disease is type 2 diabetes mellitus.